Catalyst Wire Dossier Catalyst Wire Dossier

Erythropoietin (epoetin alfa)

epoetin alfa
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Erythropoietin (epoetin alfa), covering 2010-02-10 to 2010-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery [Phase 3]

See pricing